跳至主要内容
临床试验/NCT04702633
NCT04702633已完成不适用

Non-invasive Isolation and Characterization of Prostate Tumor Cells for Prostate Cancer Diagnosis

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 127 人开始时间: 2021年3月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
127
试验地点
1
主要终点
Presence and number of prostate tumour cells in biological samples

研究概览

简要总结

The purpose of this study is to isolate and characterize tumor cells non-invasively from biological samples in patients with prostate cancer and demonstrate the ability to identify the presence and number of tumor cells before prostate biopsy.

详细描述

Prostate cancer is one of the most frequently diagnosed cancers and a leading cause of cancer death in men worldwide. Existing methods of diagnosis and monitoring of prostate cancer are inadequate due to their invasiveness, inaccuracy, cost, access uneven, etc., making difficult the diagnosis and patient's follow up. New techniques and methods are necessary to improve diagnosis.

Biological liquids might represent an attractive target to isolate prostate tumour cells for these purposes. In recent years, several studies have been carried out with the aim of reducing and / or avoiding the limits of sensitivity and specificity of current methods of screening for prostate cancer and thus obtain new biomarkers for the diagnosis and / or non-invasive monitoring.

However, due to technical and technological difficulties few studies have been performed to investigate the non-invasive isolation and direct analysis of tumour cells. Our project is therefore an innovative project which aims to study a new approach for the early diagnosis of prostate cancer, with better sensitivity and specificity.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
Male
接受健康志愿者

入选标准

  • Patients with a diagnosis of localized or metastatic prostate cancer.
  • No prior or other oncological treatment.
  • Patients undergoing prostate biopsy in the context of prostate cancer diagnosis.
  • Patients with an elevation of PSA (Prostate Specific Antigen), an abnormality on the rectal examination and / or an MRI signal motivating a prostate biopsy,
  • Patients informed and not opposed to participating in the research

排除标准

  • Patients not affiliated with French social security.
  • Patients unable to understand the protocol.
  • Patients diagnosed with another type of cancer within the past 5 years.
  • Patients prostatectomized and/or treated for prostate cancer.
  • Patients who wear a bladder catheter
  • Patients under guardianship or curatorship
  • Patients under AME

结局指标

主要结局

Presence and number of prostate tumour cells in biological samples

时间窗: One month after biopsy or until the histological diagnosis will be obtained

Cell enrichment will be carried out using the ISET® (Isolation by SizE of Tumor/Trophoblastic cells) technology. Identification will be performed by different spectroscopic and/or immune-molecular and/or cytological approaches

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Immuno-molecular Approaches for Non-invasive... | 临床试验